Home ›
Gastric Cancer Trials ›
NCT05494086
Dual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer
Dual-port laparoscopic gastrectomy (DPLG) has been widely performed in recent years for treating gastric cancers. The present study explore the safety and effect of dual-port laparoscopic distal gastrectomy (DPLDG).
Trial Details
NCT ID NCT05494086
Phase NA
Sponsor Nanfang Hospital, Southern Medical University
Status RECRUITING
Cancer Type Gastric Cancer
Interventions
Locations (sample) Guangzhou, Guangdong, China|23.11667,113.25
Key Eligibility Criteria
patients within 18--75 years old; patients with a preoperative pathological diagnosis of gastric adenocarcinoma; patients with a clinical tumor stage of T1N1,T2N0 according to the preoperative examinations (gastroscopy, ultrasound gastroscopy and computed tomo… patients with a plan to undergo laparoscopic distal gastrectomy and obtain R0 surgical results;
For full eligibility, visit ClinicalTrials.gov .
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Gastric Cancer Trials on Trialify →